The American journal of managed care
-
To evaluate whether increased placement of generic drugs on higher cost-sharing tiers in Medicare Part D is associated with coverage of multisource brand-name drugs, plan type, or product characteristics. ⋯ Although Part D plans have increasingly placed covered generic drugs on higher formulary tiers over time, this may be partly explained by a drug's clinical profile and availability of substitutes rather than preferred brand-name drug coverage.
-
Previous research on rideshare-based nonemergency medical transportation has limited generalizability due to the specific model studied, and the lack of trip-level data raises concerns of ecological fallacy.
-
Observational Study
Association of physician specialty with psoriatic arthritis treatment and costs.
To describe current psoriatic arthritis treatment and costs by provider specialty using real-world claims data. ⋯ In patients with newly diagnosed psoriatic arthritis, physician specialty was associated with different medication choices but not costs.
-
To examine whether enrollment in Medicare Advantage (MA) and fee-for-service traditional Medicare (TM) is differential by food insecurity and then examine differences in health care utilization, financial burden, care satisfaction, and health status between food-insecure enrollees in MA and TM and between food-secure enrollees in MA and TM. ⋯ MA may deliver care more efficiently to food-insecure beneficiaries than TM, but it is not better at reducing food insecurity.
-
As of May 2021, the United States remains the world leader with 33 million of 165 million cases worldwide (20%) and 590,000 of 3.4 million deaths worldwide (17%) from COVID-19. Achieving herd immunity by disease spread and vaccination may result in 2 million to 4 million total US deaths. The future perfect of the vaccine should not be the enemy of the present good, which is masking. ⋯ Any economic advantages of pandemic politics are short-lived and shortsighted in comparison with public health strategies of proven benefit that can prevent needless and mostly avoidable premature deaths from COVID-19. During the worst epidemic in more than 100 years, most Americans (75%) trust their health care providers. As competent and compassionate health care professionals, we recommend that effective strategies, especially masking, and not pandemic politics, should inform all rational clinical and public health decision-making.